Inogen Introduces Affordable and Durable Voxi 5 Oxygen Concentrator for Long-Term Care Patients
PorAinvest
martes, 24 de junio de 2025, 5:40 pm ET1 min de lectura
INGN--
Voxi 5 is the latest addition to Inogen's product portfolio, augmenting its line of portable oxygen concentrators and significantly expanding market potential while leveraging existing sales channels. The stationary oxygen concentrator delivers 1-5 liters per minute of continuous flow oxygen in a compact and efficient design, featuring an 8-layer internal gas pathway for delivering medical-grade oxygen [1][2].
Key features of the Voxi 5 include quiet operation, promoting a peaceful home environment; a compact design with lockable casters for ease of movement; a 3-year sieve bed warranty providing reliable, long-term performance; and advanced filtration for delivering medical-grade oxygen [1][2]. The device is designed to be a value-driven solution for price-sensitive customers or those in need of an additional unit for multi-room use, further solidifying Inogen's position as a pioneer in the home oxygen therapy market [1][2].
Kevin Smith, President and Chief Executive Officer of Inogen Inc., stated, "With Voxi 5, we are fulfilling our mission to make respiratory care more accessible and empowering for patients. This launch exemplifies our commitment to innovation, affordability, and enhancing the quality of life for those dependent on oxygen therapy" [1][2].
The Voxi 5 is available for purchase through Inogen's website and authorized partners. For more information, visit Inogen.com/Products [1][2].
References:
[1] https://www.marketscreener.com/quote/stock/INOGEN-INC-15810669/news/Inogen-Introduces-Voxi-5-Stationary-Oxygen-Concentrator-Setting-a-New-Standard-in-Affordable-Durab-50322315/
[2] https://www.morningstar.com/news/business-wire/20250623719328/inogen-introduces-voxi-5-stationary-oxygen-concentrator-setting-a-new-standard-in-affordable-durable-oxygen-therapy
Inogen Inc. has launched Voxi 5, a stationary oxygen concentrator that combines affordability and durability. Developed with Yuwell Medical, the device delivers 1-5 liters per minute of continuous flow oxygen and features a filtration system for medical-grade oxygen. The Voxi 5 is a value-driven solution for customers sensitive to price or those needing an additional unit for multi-room use, expanding Inogen's existing portable oxygen concentrator offerings.
Inogen Inc. (Nasdaq: INGN), a leading medical technology company specializing in innovative respiratory products for homecare use, has announced the launch of Voxi 5, a new stationary oxygen concentrator (SOC) designed to enhance access to high-quality oxygen therapy for long-term care patients in the United States. The device, developed in collaboration with Yuwell Medical, combines affordability with durability, setting a new standard in oxygen therapy [1][2].Voxi 5 is the latest addition to Inogen's product portfolio, augmenting its line of portable oxygen concentrators and significantly expanding market potential while leveraging existing sales channels. The stationary oxygen concentrator delivers 1-5 liters per minute of continuous flow oxygen in a compact and efficient design, featuring an 8-layer internal gas pathway for delivering medical-grade oxygen [1][2].
Key features of the Voxi 5 include quiet operation, promoting a peaceful home environment; a compact design with lockable casters for ease of movement; a 3-year sieve bed warranty providing reliable, long-term performance; and advanced filtration for delivering medical-grade oxygen [1][2]. The device is designed to be a value-driven solution for price-sensitive customers or those in need of an additional unit for multi-room use, further solidifying Inogen's position as a pioneer in the home oxygen therapy market [1][2].
Kevin Smith, President and Chief Executive Officer of Inogen Inc., stated, "With Voxi 5, we are fulfilling our mission to make respiratory care more accessible and empowering for patients. This launch exemplifies our commitment to innovation, affordability, and enhancing the quality of life for those dependent on oxygen therapy" [1][2].
The Voxi 5 is available for purchase through Inogen's website and authorized partners. For more information, visit Inogen.com/Products [1][2].
References:
[1] https://www.marketscreener.com/quote/stock/INOGEN-INC-15810669/news/Inogen-Introduces-Voxi-5-Stationary-Oxygen-Concentrator-Setting-a-New-Standard-in-Affordable-Durab-50322315/
[2] https://www.morningstar.com/news/business-wire/20250623719328/inogen-introduces-voxi-5-stationary-oxygen-concentrator-setting-a-new-standard-in-affordable-durable-oxygen-therapy

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios